Drug profile

The FDA adverse-event record for Bacitracin-Neomycin + Bacitracin-Neomycin-Polymyxin With Hydrocortisone Acetate 1 % + Polymyxin With Hydrocortisone Acetate 1 %

Name: Bacitracin-Neomycin + Bacitracin-Neomycin-Polymyxin With Hydrocortisone Acetate 1 % + Polymyxin With Hydrocortisone Acetate 1 % - FDA Animal Adverse Event Reports
Creator: PlainBreed
License: https://creativecommons.org/publicdomain/zero/1.0/

18 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Bacitracin-Neomycin + Bacitracin-Neomycin-Polymyxin With Hydrocortisone Acetate 1 % + Polymyxin With Hydrocortisone Acetate 1 %. See the species affected, top reactions, and outcomes below.

18
adverse-event reports: 0.0%
death-coded share: Dog
most-reported species: 3
Eye redness - top reaction

Compiled by PlainBreed Editorial, Pet Health Editorial Team

Verify with FDA CVM →

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

0.0%

Death Rate

Active Ingredients

Bacitracin-NeomycinBacitracin-Neomycin-Polymyxin With Hydrocortisone Acetate 1 %Polymyxin With Hydrocortisone Acetate 1 %

Administration Routes

OphthalmicUnknownTopicalIntraocular

Species Affected

Dog 9

Unknown 4

Cat 3

Human 1

Donkey 1

Most Affected Breeds

Unknown 5

Retriever - Labrador 2

Domestic Shorthair 1

Cat (unknown) 1

Samoyed 1

Crossbred Canine/dog 1

Ragdoll 1

Retriever - Golden 1

American Pit Bull Terrier 1

Terrier (unspecified) 1

Most Reported Reactions

Eye redness 3

Diarrhoea 3

Swollen eye 2

Vomiting 2

Underfilling, Container 2

Lack of efficacy - NOS 2

Appearance, Abnormal 1

Blepharospasm 1

Epiphora 1

Conjunctivitis 1

Vision blurred 1

Eye ache 1

Outcome Breakdown

Outcome Unknown

8 (57.1%)

Recovered/Normal

6 (42.9%)

Bacitracin-Neomycin + Bacitracin-Neomycin-Polymyxin With Hydrocortisone Acetate 1 % + Polymyxin With Hydrocortisone Acetate 1 % Adverse Event Insights

18 reports name Bacitracin-Neomycin + Bacitracin-Neomycin-Polymyxin With Hydrocortisone Acetate 1 % + Polymyxin With Hydrocortisone Acetate 1 %; 0 recorded a death outcome (0.0% of reported events, not a population-level mortality rate). Active ingredients: Bacitracin-Neomycin, Bacitracin-Neomycin-Polymyxin With Hydrocortisone Acetate 1 %, Polymyxin With Hydrocortisone Acetate 1 %. Administration routes: Ophthalmic, Unknown, Topical, Intraocular.

By species: Dog (9 reports), Unknown (4 reports), Cat (3 reports). By breed: Unknown (5), Retriever - Labrador (2), Domestic Shorthair (1).

Leading clinical signs: Eye redness (3), Diarrhoea (3), Swollen eye (2), Vomiting (2). Outcome, 14 coded reports: Outcome Unknown leads at 57.1%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.